Neohelmanthicin A
Neohelmanthicin A (compound 3A) is a phenylpropanoid compound with antitumor activity. The IC50s of Neohelmanthicin A for inhibiting leukemia cell line EL4, breast cancer cell line S180 and breast cancer cell line MCF7 are 0.13 μM, 7 μM and 23 μM respectively[1].
Product Specifications
CAS Number
[920758-09-4]
UNSPSC
12352005
Target
Others
Type
Natural Products
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/neohelmanthicin-a.html
Solubility
10 mM in DMSO
Smiles
C/C=C(C)\C(O[C@@H](C)[C@@](C)(O)C(O[C@@H](C)[C@@H](C1=CC(OC)=C(OCO2)C2=C1)OC(/C(C)=C\C)=O)=O)=O
Molecular Formula
C26H34O10
Molecular Weight
506.54
References & Citations
[1]Liu H, et al. Cytotoxic phenylpropanoids and an additional thapsigargin analogue isolated from Thapsia garganica. Phytochemistry. 2006 Dec;67 (24) :2651-8.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6190088-01 0.1 mL
FAM215A (APR-2, Putative Protein FAM215A, Putative Apoptosis-related Protein 2, APR2, C17orf88) (MaxLight 405)
Ask
View Details 
MBS6190088-02 5x 0.1 mL
FAM215A (APR-2, Putative Protein FAM215A, Putative Apoptosis-related Protein 2, APR2, C17orf88) (MaxLight 405)
Ask
View Details W2996-01C-FITC 200 µL
WNK1, ID (Serine/Threonine-protein Kinase WNK1, Protein Kinase With No Lysine 1, hWNK1, PRKWNK1, Protein Kinase, Lysine Deficient 1, Kinase Deficient Protein, Erythrocyte 65kD Protein, p65, KDP, KIAA0344) (FITC) discontinued
Ask
View Details 